Introduced
by
To mandate that opioid and benzodiazepine prescriptions be electronically transmitted to pharmacies starting in 2021.
Referred to the Committee on Health Policy and Human Services
Reported without amendment
With the recommendation that the substitute (S-2) be adopted and that the bill then pass.
Passed in the Senate 38 to 0 (details)
To mandate that prescriptions be electronically transmitted to a pharmacy of the customer's choice starting in 2021, with various exceptions, and revise other rules related to prescription drugs.
Referred to the Committee on Health Policy
Reported without amendment
Refer to the Committee on Ways and Means with the recommendation that the substitute (H-1) be adopted.
Referred to the Committee on Ways and Means
Reported without amendment
With the recommendation that the substitute (H-1) be adopted and that the bill then pass.
Passed in the House 105 to 3 (details)
To mandate that prescriptions be electronically transmitted to a pharmacy of the customer's choice starting in 2021, with various exceptions, and revise other rules related to prescription drugs.
Passed in the Senate 37 to 0 (details)
To concur with the House-passed version of the bill.
